[{"address1": "Wagistrasse 14", "city": "Schlieren", "zip": "8952", "country": "Switzerland", "phone": "41 44 755 77 00", "fax": "41 44 755 77 07", "website": "https://www.molecularpartners.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Molecular Partners AG, a clinical-stage biotechnology company, develops designed ankyrin repeat proteins therapeutics for the treatment of oncology and virology diseases in Switzerland. The company develops MP0317, a CD40 agonist designed to activate immune cells within the tumor microenvironment by anchoring to fibroblast activation protein that is in Phase I clinical trial; and MP0533, a novel tetra-specific T cell-engaging DARPin for acute myeloid leukemia. It also develops Switch-DARPin platform, a multispecific cKIT x CD16a x CD47 Switch-DARPin program for targeted and conditional immune cell activation; and Radio-DARPin Therapy (RDT) platform, a delivery system for effective and selective delivery of radioactive payloads to solid tumors. It has license and research collaboration agreements with Novartis Pharma AG to develop DARPin-conjugated radioligand therapies; and collaboration agreement with Orano Med SAS to develop novel Radio-DARPin therapeutics. Molecular Partners AG was incorporated in 2004 and is headquartered in Schlieren, Switzerland.", "fullTimeEmployees": 158, "companyOfficers": [{"maxAge": 1, "name": "Dr. Patrick  Amstutz Ph.D.", "age": 49, "title": "Co-Founder, CEO, Member of Management Board & Director", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 738566, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael Tobias Stumpp Ph.D.", "age": 52, "title": "Co-Founder, Executive VP of Projects & Member of Management Board", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert  Hendriks", "title": "Senior VP of Finance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alexander  Zurcher", "age": 49, "title": "COO & Member of Management Board", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Renate  Gloggner", "age": 54, "title": "Executive VP of People & Community and Member of Management Board", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel  Steiner Ph.D.", "title": "Senior Vice President of Research & Technology", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Seth D. Lewis", "title": "Senior Vice President of Investor Relations, Communications & Strategy", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  Pitzner", "title": "General Counsel, Compliance Officer, Senior VP Legal & Business Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Pamela A. Trail Ph.D.", "age": 68, "title": "Strategic Consultant", "yearBorn": 1956, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Anne  Goubier D.V.M., Ph.D.", "title": "Senior Vice President of Research & Early Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.31, "open": 4.35, "dayLow": 4.33, "dayHigh": 4.35, "regularMarketPreviousClose": 4.31, "regularMarketOpen": 4.35, "regularMarketDayLow": 4.33, "regularMarketDayHigh": 4.35, "payoutRatio": 0.0, "beta": 0.629, "forwardPE": -2.3532608, "volume": 575, "regularMarketVolume": 575, "averageVolume": 4446, "averageVolume10days": 4350, "averageDailyVolume10Day": 4350, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 159667008, "fiftyTwoWeekLow": 3.32, "fiftyTwoWeekHigh": 12.7, "priceToSalesTrailing12Months": 32.12616, "fiftyDayAverage": 5.02496, "twoHundredDayAverage": 5.61582, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 12622201, "profitMargins": 0.0, "floatShares": 5295015, "sharesOutstanding": 36874600, "sharesShort": 43144, "sharesShortPriorMonth": 46351, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.0011999999, "heldPercentInsiders": 0.0, "heldPercentInstitutions": 0.097229995, "shortRatio": 26.8, "shortPercentOfFloat": 0.0023999999, "impliedSharesOutstanding": 37610400, "bookValue": 3.842, "priceToBook": 1.1270171, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -54043000, "trailingEps": -1.8, "forwardEps": -1.84, "enterpriseToRevenue": 2.54, "enterpriseToEbitda": -0.21, "52WeekChange": 0.034647584, "SandP52WeekChange": 0.09506309, "quoteType": "EQUITY", "currentPrice": 4.33, "targetHighPrice": 16.87993, "targetLowPrice": 5.108177, "targetMeanPrice": 10.7253065, "targetMedianPrice": 10.456559, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 149439008, "totalCashPerShare": 4.054, "ebitda": -60229000, "totalDebt": 2444000, "quickRatio": 13.959, "currentRatio": 14.305, "totalRevenue": 4970000, "debtToEquity": 1.726, "revenuePerShare": 0.146, "returnOnAssets": -0.21441999, "returnOnEquity": -0.33982, "grossProfits": -42534000, "freeCashflow": -35437248, "operatingCashflow": -59248000, "revenueGrowth": -1.0, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -12.3173, "financialCurrency": "CHF", "symbol": "MOLN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1741988053, "regularMarketTime": 1741982400, "marketState": "CLOSED", "fiftyTwoWeekLowChangePercent": 0.30421686, "fiftyTwoWeekRange": "3.32 - 12.7", "fiftyTwoWeekHighChange": -8.37, "fiftyTwoWeekHighChangePercent": -0.6590551, "fiftyTwoWeekChangePercent": 3.4647584, "earningsTimestamp": 1741294800, "earningsTimestampStart": 1741294800, "earningsTimestampEnd": 1741294800, "earningsCallTimestampStart": 1741345140, "earningsCallTimestampEnd": 1741345140, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.8, "epsForward": -1.84, "epsCurrentYear": -1.51, "priceEpsCurrentYear": -2.8675497, "fiftyDayAverageChange": -0.6949601, "fiftyDayAverageChangePercent": -0.13830163, "twoHundredDayAverageChange": -1.28582, "twoHundredDayAverageChangePercent": -0.2289639, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-06-16", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1623850200000, "postMarketChangePercent": -0.461893, "postMarketPrice": 4.31, "postMarketChange": -0.02, "regularMarketChange": 0.01999998, "regularMarketDayRange": "4.33 - 4.35", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 4446, "fiftyTwoWeekLowChange": 1.01, "regularMarketChangePercent": 0.4640367, "regularMarketPrice": 4.33, "exchange": "NMS", "messageBoardId": "finmb_32677064", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Molecular Partners AG", "longName": "Molecular Partners AG", "trailingPegRatio": null, "__fetch_time": "2025-03-15"}]